About 46% of respondents said they somewhat or greatly preferred the idea of being able to choose from a long list of coverage providers and plan types.

Regulators accused the company of failing to make good on earlier promises to improve how it handles complaints.

When cost is removed as an option, the public rank prior authorization as the biggest problem, the latest KFF Heath Tracking Poll found.

"Without real-time supply-chain visibility, teams are forced to make critical decisions with incomplete information." said Jeff Wagner vice president of pharmacy, respiratory care and ECMO services ...

Demand for obesity and metabolic therapies is accelerating deal activity as pharma companies shift from blockbuster drugs to platform control.

The complaint, filed by the law firm Sanford Heisler Sharp McKnight, alleges that Bloomberg failed to remove two funds from its plan after they performed poorly for more than a decade.

The pharmacy benefit manager sections are riding along on a "minibus" ferrying government funding provisions through Congress.

The department may also set rules for fully insured plans and it says ERISA fee disclosure rules apply to dental and vision plans.

Mangione still faces a second-degree murder count and other charges in a separate case in New York state, where the death penalty is unconstitutional.

This session pulls back the curtain on creative funding strategies designed to de-risk GLP-1 coverage, allowing you to bring ...

GLP-1s may delay insulin initiation for many Type 2 patients, potentially moderating long-term growth for traditional diabetes therapies. Meanwhile, biosimilars have added competition in the insulin ...

Two-thirds of survey respondents say they worry about being able to afford health care for themselves and their family, ranking higher than utilities, food and groceries, housing and gas.